Dynarex Expands Wound Care Portfolio
June 23, 2026
Dynarex Corporation has announced the expansion of its wound care and specialized treatment product offerings with the introduction of new collagen dressings, nasal sponges, and additional products designed for post-operative and specialty care settings.
Event: Unavoidable Pressure Injuries, Terminal Ulceration, and Skin Failure
November 9, 2017
By Jeffrey Levine MD
Please join me Thursday, November 16 from 3:00-4:00pm EST for a free webinar presented by myself and Elizabeth A. Ayello, PhD, RN, ACNS-BC, CWOCN, ETN, MAPWCA, FAAN sponsored b...
Frequently Asked Questions: Wound Care Challenges and Solutions During the COVID-19 Pandemic
June 29, 2020
By Marcia Nusgart, RPh; Lee C. Rogers, DPM; Mark D. Iafrati, MD, FACS; Paul J. Kim, DPM, MS, FACFAS; Karen Ravitz, JD; Stephanie Woelfel, PT, DPT, CWS, FACCWS; and Emily Greenstein, APRN,CNP, CWON
...
How 100 Wounds Led to a 20-Year Mission
July 19, 2017
By Jeanne Cunningham, Founder of WoundSource
After seeing about 100 pictures of wounds, I was beginning to feel sick. The year was 1985 and there I was, a recent college graduate in my 20s, sitting...
RedDress Launches ActiGraft PRO with G-Code Reimbursement Status
July 20, 2023
TEL AVIV, Israel and JACKSONVILLE, FL - (July 18, 2023) ActiGraft PRO is now commercially available in the US and eligible for reimbursement from Medicare and Medicare Advantage via NCD 270.3 and G-0465 & G-0460 codes. Medicare and Medicare Advantage plans will now reimburse $1,726 per application for up to 20 applications. This eligibility applies to diabetic foot ulcer (DFU) treatment.
Vibrio vulnificus: What Are the Risks
September 15, 2023
On September 1, the Centers for Disease Control and Prevention (CDC) issued a health advisory regarding the pathogen Vibrio vulnificus. V. vulnificus is a rare but aggressive species of Vibrio bacteri...
